← Compare landing
Dipharma vs ESTEVE CDMO
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Dipharma | ESTEVE CDMO |
|---|---|---|
| Summary | Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970. | ESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities. |
| Services |
| Data not yet provided. |
| Modalities |
| Data not yet provided. |
| Development capabilities |
| Data not yet provided. |
| Manufacturing capabilities |
| Data not yet provided. |
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/dipharma/esteve-cdmo.md